No nothing about diversity. The primary target still in cancer oncology. The goal is not HIV but inflammation.
New Appointment...Mathieu Angin, page-3
-
- There are more pages in this discussion • 14 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add IMM (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
31.0¢ |
Change
-0.020(6.06%) |
Mkt cap ! $486.6M | |||
| Open | High | Low | Value | Volume |
| 32.0¢ | 32.3¢ | 30.5¢ | $768.4K | 2.459M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 23 | 232768 | 30.5¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 31.0¢ | 46685 | 13 |
View Market Depth
| Last trade - 13.33pm 26/11/2024 (20 minute delay) ? |
| IMM (ASX) Chart |
